ChromaDex Corp. has announced that its flagship ingredient, Tru Niagen (nicotinamide riboside), will be in Nestlé Health Science’s new Cellular Energy product under the new Celltrient brand.
Image courtesy of Nestlé Health Science
ChromaDex Corp. (Los Angeles, CA) has announced that its flagship ingredient, Tru Niagen (nicotinamide riboside), will be in Nestlé Health Science’s (Lausanne, Switzerland) new Cellular Energy product under the new Celltrient brand. The new product, one of a range of three in Nestlé’s new line of Cellular Nutrition products, contains 250 mg of Tru Niagen in the form of a protein-based flavored drink mix. Tru Niagen has been shown in research to boost NAD+ levels, supporting cellular defense and repair for healthy aging.
“We are pleased to see the Nestlé Health Science launch of Celltrient Cellular Energy,” said ChromaDex CEO Rob Fried, in a press release. “Tru Niagen, the only proprietary form of NR, provides healthy aging and energy support at the cellular level by safely and effectively increasing NAD+ levels.”
"Celltrient is an important advancement in our goal to bring new benefits to consumers and patients. Research has shown that cellular nutrients can be a game changer in the way people manage how they age," said Greg Behar, CEO of Nestlé Health Science, of the new brand. "At Nestlé Health Science, we're thrilled to be at the forefront of the revolution in cellular nutrition. As people age, we know that there is a gap between how they want to feel and how they are actually feeling. With Celltrient, we can help people transform the way their cells perform with age, ultimately helping them improve the health of their cells with nutrition."
The partnership between ChromaDex and Nestlé Health Science began in 2018 when the two signed a license and supply agreement for Niagen. ChromaDex Corp.’s trademark ingredient is also being used by Persona Nutrition, the personalized nutrition service acquired by Nestlé Health Science in 2019.